Boditech Media
-
PRESS RELEASE
Boditech Med has entered into a license agreement with SphingoTec
Worldwide licensing agreement signed to develop and offer penKid as test on Boditech's POCT immunoassay analyzers
-
PRESS RELEASE
Boditech Med has acquired the export license of Free T4 diagnostic kits
Targeting the global thyroid diagnostic market, which is estimated to be worth KRW 3.4 trillion by 2028
-
PRESS RELEASE
Boditech Med has obtained domestic use approval of Boditech Quick™ COVID-19 Ag Saliva from the MFDS
The most advanced COVID-19 Ag home test with saliva sample (sensitivity 93.8%, specificity 99.5%)
-
NEWS
2022 Boditech Med Photo Contest - Winner Announcement
Congratulations to the Winners!
-
NEWS
2022 Boditech Med Photo Contest
Contest Period: September 23rd - October 22nd
-
PRESS RELEASE
Boditech Med had a grand opening ceremony for the new R&D Center
Planning to become a global leading IVD company with continuous R&D investment & development of new IVD solutions
-
NEWS
Boditech Med hold 2022 Southeast Asia Regional Partners Summit in Singapore
Established market strategy with our partners from 8 countries for Southeast Asia market
-
NEWS
Boditech Med visited India for regional meeting with our partners and customers
Planning to secure the market share in India IVD market
-
NEWS
CEO Interview: Boditech Med’s Latest IVD Solutions at AACC 2022
Key insights of Boditech Med's IVD solutions
-
PRESS RELEASE
Boditech Med has obtained the export license of four TDM products
Aiming to be a market leader in the global TDM market with diverse distribution channels